Open

Coming up

Don't miss

Replay


LATEST SHOWS

IN THE PAPERS

NETANYAHU SAYS GAZA OPERATION WILL NOT END QUICKLY

Read more

BUSINESS DAILY

Argentina braced for another debt default

Read more

AFRICA NEWS

Ebola virus : Liberia shuts most border points

Read more

MEDIAWATCH

"What would you do?"

Read more

DEBATE

Too Late for Sanctions? Pressure Mounts on Russia over Ukraine (part 2)

Read more

DEBATE

Too Late for Sanctions? Pressure Mounts on Russia over Ukraine

Read more

FOCUS

As France’s Carrefour pulls out, what next for India’s retail market?

Read more

#TECH 24

Internet of Things

Read more

THE WORLD THIS WEEK

The World This Week - July 25th, 2014 (part 2)

Read more

  • Israeli strikes target symbols of Hamas power

    Read more

  • US says Russia violated arms treaty by testing cruise missile

    Read more

  • Argentina in last-ditch effort to avert default

    Read more

  • Libya oil tanker fire blazes out of control

    Read more

  • In pictures: From Gaza to Mosul, bittersweet end of Ramadan for Muslims

    Read more

  • France offers asylum to Iraqi Christians

    Read more

  • Moroccan police arrest French al-Qaeda recruiter

    Read more

  • Israel warns of ‘prolonged’ campaign in Gaza

    Read more

  • French mayor files complaint against US father who risked kids’ lives on Mont Blanc

    Read more

  • French footballer Griezmann headed to Atletico Madrid

    Read more

  • Luc Besson’s sci-fi thriller ‘Lucy’ tops US box office

    Read more

  • Video: Slaviansk mourns mass grave victims

    Read more

  • France honours those lost on Air Algérie Flight AH5017

    Read more

  • Video: Ethiopia turns to wine to boost image, economy

    Read more

  • Thousands gather in Marseille in support of Israel

    Read more

  • As France’s Carrefour pulls out, what next for India’s retail market?

    Read more

  • Liberia tightens border controls to curb Ebola outbreak

    Read more

SCIENCE

Baxter produces first commercial swine flu vaccine

Text by NEWS WIRES

Latest update : 2009-08-06

US pharmaceutical company Baxter says it has completed its first commercial batches of swine flu vaccine and is entering talks over its distribution in several flu-hit countries.

REUTERS - Baxter International Inc said on Wednesday it completed its first commercial batches of H1N1 vaccine in late July and is discussing distribution plans with national health authorities.

 

The swine flu vaccine, to be sold under the brand name Celvapan, is made using Baxter's cell culture process, which is designed to be faster than traditional vaccine production methods, where virus samples must be put into specially raised chicken eggs to grow.

 

Baxter has supply contracts with five countries, including the U.K., Ireland and New Zealand, but not the United States, said spokeswoman Deborah Spak.

 

"Mainly because of our production scale," she said, noting that the company currently has orders for 80 million doses.

 

Several other companies are using conventional methods to develop H1N1 swine flu vaccines. Novartis AG has started human testing of its vaccine candidates while Sanofi-Aventis SA, the world leader in flu shots, will commence within days, company officials said this week.

 

GlaxoSmithKline PLC, the other "big three" flu vaccine supplier, said it would initiate clinical studies later this month.

 

H1N1 swine flu, which first surfaced in Mexico in April and was declared a pandemic by the World Health Organization (WHO) in June, has infected millions and killed an unknown number.

 

Healthcare officials are relying on a vaccine to contain the spread of disease, providing a potential sales windfall for those companies that are able to deliver quickly and in large volume.

 

AstraZeneca PLC, whose MedImmune unit makes smaller amounts of a flu vaccine that is sprayed into the nose rather than injected, said it would start clinical trials in the United States around Aug. 17.

 

Baxter said it tested a "mock-up" vaccine made with a different pandemic strain in several clinical trials, clearing the way for European licensure. Confirmatory clinical trials to evaluate the safety and immunogenicity of Celvapan in adults, the elderly and children are scheduled to begin in August.

 

Regulators in Europe and the United States plan to fast-track approval of swine flu vaccines to ensure they are available for the start of the northern hemisphere winter.

 

At the moment swine flu is rated only a "moderate" pandemic by WHO standards but it could worsen as temperatures cool, making conditions better for the virus.
 

Date created : 2009-08-06

COMMENT(S)